M4MM
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
EU Cannabis Imports Explained: Rules, Regulations, Safety & Quality Control
LOS ANGELES – Germany's medical Cannabis imports reached 56.9 tons in Q3 2025, a 19% jump from the prior period and a fresh record that highlights the market's relentless pull. With an estimated 900k prescriptions ...
Gallup Reveals First Dip in Years for Cannabis Legalization Public Support
LOS ANGELES – A fresh Gallup survey reveals that 64% of American adults now back making Cannabis use legal, a figure that marks the first decline in overall support since 2019 and pulls back from ...
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to ...
Planet 13 Reports Q3 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening ...
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
Trump Signs Funding Measure Ending Historic 43-Day Government Shutdown, Bans Hemp-Derived THC Products
WASHINGTON – President Donald Trump signed a bipartisan spending package that reopens the federal government after a 43-day impasse, marking the longest such closure in American history. Tucked into the legislation, however, are new limits ...
Opinion: Lean In? Sometimes You Have To Lean Out
LOS ANGELES- For years, women have been told that if we want to succeed, we need to “lean in.” Work twice as hard to get half as much. Push through. Prove ourselves. Be unstoppable. And ...
OPINION: Careful What You Wish For, You Might End Up With A 12-Inch Pianist
LOS ANGELES- The regulated cannabis industry should be collectively objecting to the language in the Big Beautiful Bill that effectively makes intoxicating hemp products illegal in 12 months. They should be screaming from the roof ...
Flower by Edie Parker Teams Up with Verano for Florida Cannabis Debut, Spotlights Rapper JT in Promo Campaign
MIAMI – Flower by Edie Parker, a female-founded, premium Cannabis brand known for its vibrant designs, has struck an exclusive deal with Verano Holdings Corp. to roll out its products across the Sunshine State's medical ...
AbbVie Reveals $900M Upfront Payment in Psychedelic Deal, Signaling Strong Bet on Bretisilocin
CHICAGO – AbbVie Inc. disclosed in a recent securities filing that it handed over $900 million in cash at the outset of its acquisition of bretisilocin, the experimental psychedelic compound acquired from Gilgamesh Pharmaceuticals aimed ...
Rubicon Organics Secures $4M Financing for Facility Upgrades
VANCOUVER, BC – Rubicon Organics Inc. closed a $4 million credit package with Community Savings Credit Union to finance upgrades at its production sites. The deal breaks down into a $3 million term loan carrying ...
The Intoxicating Hemp Ban Is About to Become Law — and It’s a Pyrrhic Victory for Cannabis
LOS ANGELES- The federal government just erased a $20-billion industry under the guise of “closing a loophole.” But rather than protecting consumers, Washington has dealt a crippling blow to both hemp and legal Cannabis — ...
Senate Spending Package Eyes Hemp THC Crackdown as Shutdown Continues, Trump Backs Restrictions
WASHINGTON – A bipartisan spending package drafted to end the nation's longest government shutdown now includes a provision that would sharply curtail sales of hemp-derived THC products, garnering White House endorsement and fierce opposition from ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...
